ASX:DRUG Holdings Information

ASX:DRUG is an equity ETF with a total of 82 individual holdings. The top holdings are Johnson & Johnson stock at 8.24%, Eli Lilly and Company at 7.43%, AbbVie at 5.58%, ROCHE HOLDING AG at 5.39%, and AstraZeneca at 5.22%.

Total Holdings

Top 10 Percentage

50.20%

Asset Class

Equity

ETF Category

Health Care

Assets

179.00M

PE Ratio

22.81

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	JNJ	Johnson & Johnson	8.24%	41,805
2	LLY	Eli Lilly and Company	7.43%	8,991
3	ABBV	AbbVie Inc.	5.58%	30,667
4	ROG.SE	ROCHE HOLDING AG	5.39%	14,180
5	LON: AZN	AstraZeneca PLC	5.22%	31,647
6	NOVN.SE	NOVARTIS AG	4.98%	37,158
7	MRK	Merck & Co., Inc.	4.13%	42,819
8	UNH	UnitedHealth Group Incorporated	3.40%	14,662
9	TMO	Thermo Fisher Scientific Inc.	2.96%	7,022
10	AMGN	Amgen Inc.	2.89%	9,400
11	ABT	Abbott Laboratories	2.86%	30,356
12	ISRG	Intuitive Surgical, Inc.	2.54%	6,189
13	GILD	Gilead Sciences, Inc.	2.52%	21,659
14	PFE	Pfizer Inc.	2.18%	99,257
15	SYK	Stryker Corporation	2.11%	6,755
16	DHR	Danaher Corporation	2.09%	12,331
17	NOVOB.DC	NOVO NORDISK A/S	2.02%	66,145
18	LON: GSK	GSK plc	1.96%	82,927
19	BMY	Bristol-Myers Squibb Company	1.86%	37,629
20	MDT	Medtronic plc	1.76%	22,380
21	SAN.FP	SANOFI	1.67%	21,680
22	EL.FP	ESSILORLUXOTTICA SA	1.48%	6,468
23	BSX	Boston Scientific Corporation	1.47%	24,053
24	VRTX	Vertex Pharmaceuticals Incorporated	1.38%	3,543
25	HCA	HCA Healthcare, Inc.	1.26%	2,953

Showing 25 of 82 holdings

Subscribe to see the full list

Activate Now

As of Feb 26, 2026